CIMINO, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.970
AS - Asia 5.009
EU - Europa 3.395
SA - Sud America 1.495
AF - Africa 130
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 7
Totale 19.025
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.725
SG - Singapore 1.357
HK - Hong Kong 1.305
CN - Cina 1.271
BR - Brasile 1.187
GB - Regno Unito 987
IT - Italia 678
VN - Vietnam 499
SE - Svezia 485
RU - Federazione Russa 302
DE - Germania 252
BG - Bulgaria 155
CA - Canada 155
UA - Ucraina 112
AR - Argentina 105
ID - Indonesia 104
TR - Turchia 98
FI - Finlandia 88
FR - Francia 84
IN - India 62
EC - Ecuador 59
JP - Giappone 52
KR - Corea 49
AT - Austria 43
BD - Bangladesh 39
EG - Egitto 36
IQ - Iraq 36
NL - Olanda 36
CO - Colombia 35
ES - Italia 35
MX - Messico 35
ZA - Sudafrica 32
PL - Polonia 30
CL - Cile 29
PE - Perù 25
IE - Irlanda 23
PY - Paraguay 19
MA - Marocco 17
MY - Malesia 17
UZ - Uzbekistan 17
VE - Venezuela 17
BZ - Belize 16
CZ - Repubblica Ceca 16
UY - Uruguay 16
KE - Kenya 13
LT - Lituania 13
IL - Israele 12
PK - Pakistan 12
AU - Australia 11
BE - Belgio 9
AE - Emirati Arabi Uniti 8
AL - Albania 8
IR - Iran 8
TH - Thailandia 8
DZ - Algeria 7
GT - Guatemala 7
SA - Arabia Saudita 7
TN - Tunisia 7
DO - Repubblica Dominicana 6
NP - Nepal 6
NZ - Nuova Zelanda 6
PA - Panama 6
PT - Portogallo 6
EU - Europa 5
KG - Kirghizistan 5
RO - Romania 5
AZ - Azerbaigian 4
CH - Svizzera 4
DK - Danimarca 4
JM - Giamaica 4
KZ - Kazakistan 4
MK - Macedonia 4
SI - Slovenia 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
CR - Costa Rica 3
CY - Cipro 3
GE - Georgia 3
HU - Ungheria 3
JO - Giordania 3
KW - Kuwait 3
MN - Mongolia 3
NO - Norvegia 3
PH - Filippine 3
AO - Angola 2
CV - Capo Verde 2
GL - Groenlandia 2
LV - Lettonia 2
LY - Libia 2
MU - Mauritius 2
NG - Nigeria 2
OM - Oman 2
PR - Porto Rico 2
PW - Palau 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BF - Burkina Faso 1
BH - Bahrain 1
Totale 19.005
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.575
Hong Kong 1.300
Fairfield 906
Singapore 855
Ashburn 831
Chandler 459
London 449
Houston 448
Woodbridge 443
Nyköping 386
Southend 364
Seattle 342
Cambridge 299
Wilmington 299
Beijing 266
Ann Arbor 227
Hefei 213
Ho Chi Minh City 197
Princeton 173
Los Angeles 170
Jacksonville 166
Sofia 153
Modena 148
San Diego 147
New York 144
Dearborn 139
Toronto 127
Dallas 102
São Paulo 102
Moscow 101
Hanoi 100
The Dalles 95
Buffalo 87
Jakarta 61
Shanghai 60
Chicago 59
Nuremberg 50
Redondo Beach 50
Helsinki 49
Seoul 47
Milan 44
Eugene 38
Rio de Janeiro 38
Rome 37
Columbus 35
Council Bluffs 35
Munich 34
San Jose 33
Tokyo 33
Izmir 27
Frankfurt am Main 26
Cairo 25
Guangzhou 25
Brasília 24
Salt Lake City 24
Curitiba 23
Vienna 23
Warsaw 23
Haiphong 22
Dublin 21
Belo Horizonte 20
Biên Hòa 20
Porto Alegre 20
Guayaquil 19
Lauterbourg 19
Quito 18
Santiago 18
Kilburn 17
Orem 17
Belize City 16
Lima 16
Bologna 15
Brooklyn 15
Denver 15
Elk Grove Village 15
Redwood City 15
Reggio Emilia 15
Tashkent 15
Turin 15
Da Nang 14
Palermo 14
Thái Bình 14
Baghdad 13
Johannesburg 13
Kuala Lumpur 13
Wuhan 13
Boardman 12
Campinas 12
Chiswick 12
Genoa 12
Kent 12
Montevideo 12
Paris 12
Salvador 12
Stockholm 12
Amsterdam 11
Asunción 11
Atlanta 11
Bengaluru 11
Falls Church 11
Totale 13.356
Salva come PNG Salva come JPEG
Nome #
-463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis 276
Assessment of the Anti-inflammatory Effects of NORFLO® ORO in Acute Relapses of HLA-B27-associated Autoimmune Uveitis: A Multicenter, Randomized, Placebo-controlled, Double-blind Clinical Study 274
Visual loss and other cranial ischaemic complications in giant cell arteritis 266
G/R 241 polymorphism of intercellular adhesion molecule 1 (ICAM-1) is associated with Fuchs uveitis 254
Comparison between colour duplex sonography findings and different histological patterns of temporal artery 237
Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis 236
Interferon Alpha-2a for the Treatment of Post-Infectious Uveitis Secondary to Presumed Intraocular Tuberculosis 225
Increased expression of interleukin-22 in patients with giant cell arteritis 224
Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study 222
Higher Frequencies of Lymphocytes Expressing the Natural Killer Group 2D Receptor in Patients With Behçet Disease 221
Histopathologic Findings of Patients With Biopsy-Negative Giant Cell Arteritis Compared to Those Without Arteritis: A Population-Based Study 220
Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study 219
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab 219
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study 214
Long-term remission in biopsy proven giant cell arteritis: A retrospective cohort study 213
Ophthalmic manifestations of cat scratch disease 213
MicroRNA markers of inflammation and remodelling in temporal arteries from patients with giant cell arteritis 211
Adalimumab in the treatment of immune-mediated diseases 208
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease 207
Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis 205
Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis 194
The causes of uveitis in a referral centre of Northern Italy 194
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia 193
PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis 189
Searching for viral antibodies and genome in intraocular fluids of patients with Fuchs uveitis and non-infectious uveitis 185
Erratum to: Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990 consecutive cases (International Ophthalmology, (2017), 10.1007/s10792-016-0434-x) 185
Tuberculous uveitis, a resurgent and underdiagnosed disease 183
Interleukin-10 promoter polymorphisms in giant cell arteritis 181
Small-vessel vasculitis surrounding an uninflamed temporal artery and isolated vasa vasorum vasculitis of the temporal artery: two subsets of giant cell arteritis 180
Standardization of red flags for referral to rheumatologists and ophthalmologists in patients with rheumatic diseases and ocular involvement: a consensus statement 177
The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases 176
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis 171
Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study 169
Assessment of disease activity in large-vessel vasculitis: Results of an international delphi exercise 167
Flares in Biopsy-Proven Giant Cell Arteritis in Northern Italy: Characteristics and Predictors in a Long-Term Follow-Up Study 163
Quasi cieco all'improvviso 161
The therapeutic potential of tuftsin-phosphorylcholine in giant cell arteritis 160
Association Between Specimen Length and Number of Sections and Diagnostic Yield of Temporal Artery Biopsy for Giant Cell Arteritis 160
Ebv-driven lymphoproliferative disorders and lymphomas of the gastrointestinal tract: A spectrum of entities with a common denominator (part 3) 157
Anterior ischaemic optic neuropathy in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a case report and review of the literature 154
Ebv-driven lymphoproliferative disorders and lymphomas of the gastrointestinal tract: A spectrum of entities with a common denominator (part 2) 149
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative 148
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 1: Guidelines for Initiating Antitubercular Therapy in Tubercular Choroiditis 144
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial 140
Toll-like receptor 4 (TLR4) gene polymorphisms in giant cell arteritis 139
Effectiveness of Infliximab and Interferon Alpha-2a for the Treatment of Behçet’s Uveitis: Customizing Therapy according to the Clinical Features 137
Cutaneous Involvement in Diseases with Plasma Cell Differentiation: Diagnostic Approach 132
Clinical Features and Prevalence of Spondyloarthritis in a Cohort of Italian Patients Presenting with Acute Nongranulomatous Anterior Uveitis 132
Distribution patterns of 18F-fluorodeoxyglucose in large vessels of Takayasu's and giant cell arteritis using positron emission tomography 131
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: A population-based study 129
Aqueous Humor Analysis in Overlapping Clinical Diagnosis of Cytomegalovirus and Rubella Virus Anterior Uveitis 124
Assessment and classification of choroidal vasculitis in posterior uveitis using indocyanine green angiography 121
Interleukin-6 promoter polymorphism at position -174 in giant cell arteritis 120
Uveitis and other ocular complications following covid-19 vaccination 118
Autoimmune uveitis in children: clinical correlation between antinuclear antibody positivity and ocular recurrences 116
Interferon Alpha-2a Treatment for Post-Uveitic Refractory Macular Edema 115
Reggio Emilia (Northern Italy) Interdisciplinary Uveitis Clinic: What We Have Learned in the Last 20 Years 112
Vogt–Koyanagi–Harada patients show higher frequencies of circulating NKG2Dpos NK and NK T cells 111
Relapses and long-term remission in large vessel giant cell arteritis in northern Italy: Characteristics and predictors in a long-term follow-up study 110
Corrigendum to: Increased expression of interleukin-22 in patients with giant cell arteritis 109
Testo-atlante sulle Uveiti 109
Abatacept for Severe Anti-Tumor Necrosis Factor alpha Refractory Juvenile Idiopathic Arthritis-Related Uveitis 109
Uveitis in Tumor Patients Treated with Immunological Checkpoint- and Signal Transduction Pathway-Inhibitors 109
Assessement and classification of choroidal vasculitis in intraocular inflammation using indocyanine green angiography 108
Clinical Relevance of Subcentimetric Lymph Node Biopsy in the Diagnosis of Ocular Sarcoidosis 107
Survival and Recurrence in Vitreoretinal Lymphoma Simulating Uveitis at Presentation: The Possible Role of Combined Chemotherapy 107
Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the collaborative ocular tuberculosis study (COTS)-1 106
Cytokine Profiling in Aqueous Humor Samples From Patients With Non-Infectious Uveitis Associated With Systemic Inflammatory Diseases 105
Infantile-Onset Spinocerebellar Ataxia Type 5 (SCA5) with Optic Atrophy and Peripheral Neuropathy 105
Cataract Surgery with Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-Associated Uveitis: Outcomes in the Era of Biological Therapy 104
Role of miR-146a and miR-146b in Giant Cell Arteritis. 103
Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome 102
Acute zonal occult outer retinopathy complex disease: Lessons learned about choroid, photoreceptors, and retinal function 102
Surgical management of post-uveitic epiretinal membranes 100
miR-146a and miR-146b regulate the expression of ICAM-1 in giant cell arteritis 99
Insight into giant cell arteritis pathogenesis by NanoString nCounter gene expression profiling in temporal artery biopsies 98
Efficacy of Rituximab Treatment in Vogt-Koyanagi-Harada Disease Poorly Controlled by Traditional Immunosuppressive Treatment 98
Eosinophilic giant cell arteritis: A different subset of disease? 98
Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies 97
Twenty-four Month Outcomes in the Collaborative Ocular Tuberculosis Study (COTS)-1: Defining the "Cure" in Ocular Tuberculosis 95
Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990 consecutive cases 94
Yag laser iridotomy in pigment dispersion syndrome: 10 years later 93
Aqueous tap and rapid diagnosis of cytomegalovirus anterior uveitis: the Reggio Emilia experience 92
Anterior Chamber Inflammation After Cataract Surgery: A Randomized Clinical Trial Comparing Bromfenac 0.09% to Dexamethasone 0.1% 92
Fluorescein angiography findings in eyes with lamellar macular hole and epiretinal membrane foveoschisis 92
Unilateral Ocular Pseudopemphigoid in a Patient With Glaucoma 90
Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma 89
Interleukin-6 expression in inflamed and non-inflamed temporal arteries from patients with giant cell arteritis 89
Scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis) 89
Beta-adrenergic antagonists in the treatment of glaucoma 87
Ocular inflammatory events following COVID-19 vaccination: a multinational case series 87
Cogan’s syndrome 86
Retinocoroidopatia tipo Birdshot 84
From A… to… Z(OOR): The Clinical Spectrum of Acute Zonal Occult Outer Retinopathy 82
The Collaborative Ocular Tuberculosis Study (COTS) Consensus (CON) Group Meeting Proceedings 80
Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III 80
Vitreoretinal lymphomas misdiagnosed as uveitis: Lessons learned from a case series 79
Differential inflammatory involvement in retina and choroid in birdshot chorioretinopathy 78
Diagnosis and Treatment of Listeria monocytogenes Endophthalmitis: A Systematic Review 78
The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Review of 447 Patients with Tubercular Intermediate Uveitis and Panuveitis 78
Totale 14.380
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.066
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021767 0 0 0 0 0 90 106 173 84 132 96 86
2021/20221.865 47 92 97 58 19 67 449 59 197 53 443 284
2022/20231.776 278 178 176 93 147 219 34 171 203 23 110 144
2023/20241.788 35 73 74 100 390 131 66 225 296 97 56 245
2024/20255.374 95 46 75 337 1.158 840 495 239 685 294 330 780
2025/20264.599 556 376 1.082 1.538 904 143 0 0 0 0 0 0
Totale 19.279